In one of our previous studies, we constructed CD44-shRNA plasmids and transfected them into ovarian cancer SKOV-3 cells by PEG-MZF-NPs; CD44 gene expression was significantly inhibited, indicating CD44-shRNA has a good potential to treat ovarian cancer (15). Here, CD44 is linked to ovarian carcinoma.